Skip to content

Debt-to-equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
2.2×-0.6×
Labcorp Holdings logo
Labcorp HoldingsLH
0.8×0.0×
Quest Diagnostics logo
Quest DiagnosticsDGX
0.9×-0.1×
NeoGenomics logo
NeoGenomicsNEO
0.1×0.0×
Natera, Inc. logo
Natera, Inc.NTRA
0.1×0.0×
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
0.2×0.0×

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Current ratio5.3×-1.0×

Where this comes from

Calculated from Fulgent Genetics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s debt-to-equity?
Fulgent Genetics, Inc. (FLGT) reported debt-to-equity of 0× in Q1 2026.
How has Fulgent Genetics, Inc.'s debt-to-equity changed year-over-year?
Fulgent Genetics, Inc.'s debt-to-equity increased by 50.0% year-over-year, from 0× to 0×.
What is the long-term trend for Fulgent Genetics, Inc.'s debt-to-equity?
Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s debt-to-equity has grown at a 27.2% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.